NCT03635684View on ClinicalTrials.gov

Evaluation of Efficacy and Safety of Subcutaneous Acetaminophen

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

May 17, 2018

Primary Completion Date

June 1, 2020

Study Completion Date

June 1, 2020

Conditions
PainFeverDrug EffectDrug Reaction
Interventions
DRUG

Acetaminophen

"Subcutaneous infusion of Acetaminophen over 20 to 30 minutes, with evaluation of:~* local side effects;~* pain and/or fever;~at time of infusion, after 30 minutes, 60 minutes and 180 minutes."

Trial Locations (1)

Unknown

Hotel-Dieu de France, Beirut

All Listed Sponsors
lead

Saint-Joseph University

OTHER

NCT03635684 - Evaluation of Efficacy and Safety of Subcutaneous Acetaminophen | Biotech Hunter | Biotech Hunter